… used to identify baseline risk factors associated with weight gain in individuals initiating
antiretroviral therapy, resulting in the inclusion of the above 8 baseline risk factors in the mixed-…

… programmatic factors associated with retention in care during the pre-antiretroviral therapy
(… This review suggests a combination of interventions to retain specific groups at risk for …

… and adherence to antiretroviral therapy. … with antiretroviral therapy. Findings from available
studies show a substantial and consistent relationship between adherence to antiretroviral …

… -infected individuals and inform guidelines for risk factor management. HIV, cause-specific
mortality, antiretroviral therapy Antiretroviral therapy (ART) has dramatically reduced mortality …

… In the DAD population we have observed a high prevalence of multiple risk factors for CVD,
particularly among patients currently receiving an antiretroviral therapy regimen containing …

… Highly active antiretroviral therapy (HAART) was defined as combination antiretroviral
therapy with at least 3 drugs, containing at least 1 protease inhibitor or a nonnucleoside reverse …

… antiretroviral drug were not statistically significant risk factors for … injury according to each
antiretroviral drug. In multivariate … risk for hepatotoxicity of highly active antiretroviral therapy in …

… Protease inhibitor-based antiretroviral therapy is associated … , antiretroviral drug history,
“classical” vascular risk factors and … We examined the role of combination antiretroviral therapy at …

… non-adherence to the antiretroviral therapy and biological, social-behavior and demographics
and economic factors, factors related to the disease and/or treatment, factors related to life …

… use and the selected CVD risk factors (hypertension, diabetes mellitus, and dyslipidemia). …
the 3 key concepts; anti-retroviral therapy; cardiovascular disease risk factors (hypertension, …